MEDP logo

Medpace Holdings Inc. (MEDP)

$519.96

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on MEDP

Market cap

$14.85B

EPS

15.89

P/E ratio

26.3

Price to sales

4.46

Dividend yield

--

Beta

1.185245

Price on MEDP

Previous close

$512.79

Today's open

$517.87

Day's range

$512.55 - $533.09

52 week range

$305.69 - $628.92

Profile about MEDP

CEO

August J. Troendle

Employees

6200

Headquarters

Cincinnati, OH

Exchange

Nasdaq Global Select

Shares outstanding

28559689

Issue type

Common Stock

MEDP industries and sectors

Healthcare

Biotechnology & Life Sciences

News on MEDP

Medpace (MEDP) Advances While Market Declines: Some Information for Investors

Medpace (MEDP) reached $519.96 at the closing of the latest trading day, reflecting a +1.4% change compared to its last close.

news source

Zacks Investment Research • Jun 25, 2026

news preview

Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call the following morning, Thursday, July 23, 2026, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended you joi.

news source

Business Wire • Jun 16, 2026

news preview

Medpace (MEDP) Suffers a Larger Drop Than the General Market: Key Insights

Medpace (MEDP) closed the most recent trading day at $461.6, moving 1.26% from the previous trading session.

news source

Zacks Investment Research • Jun 16, 2026

news preview

CON vs. MEDP: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical Services sector might want to consider either Concentra Group (CON) or Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?

news source

Zacks Investment Research • Jun 12, 2026

news preview

Why the Market Dipped But Medpace (MEDP) Gained Today

Medpace (MEDP) closed at $466.79 in the latest trading session, marking a +1.94% move from the prior day.

news source

Zacks Investment Research • Jun 9, 2026

news preview

MEDP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026

NEW YORK--(BUSINESS WIRE)---- $MEDP #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) and reminds investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The fir.

news source

Business Wire • Jun 8, 2026

news preview

Safirstein Law LLC Announces That A Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP)

RIDGEWOOD, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- RIDGEWOOD, N.J., June 8, 2026 (GLOBE NEWSWIRE) -- Safirstein Law LLC announces that a class action lawsuit has been filed on behalf of shareholders against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ:MEDP).  

news source

GlobeNewsWire • Jun 8, 2026

news preview

Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, June 8, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Medpace securities between April 22, 2025 and February 9, 2026, both dates inclusive (the "Class Period").

news source

PRNewsWire • Jun 8, 2026

news preview

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Highlights Class Action Against Medpace Holdings (MEDP) and Upcoming Lead Plaintiff Deadline of June 8, 2026

NEW YORK--(BUSINESS WIRE)---- $MEDP #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) and reminds investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The fir.

news source

Business Wire • Jun 8, 2026

news preview

INVESTOR DEADLINE: Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

San Diego, California--(Newsfile Corp. - June 8, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, all dates inclusive (the "Class Period"), have until today, Monday, June 8, 2026 to seek appointment as lead plaintiff of the Medpace class action lawsuit. Captioned Durbin v.

news source

Newsfile Corp • Jun 8, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Medpace Holdings Inc.

Open an M1 investment account to buy and sell Medpace Holdings Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in MEDP on M1